HEADER TRANSFERASE 05-JUN-15 5BVW
TITLE FRAGMENT-BASED DISCOVERY OF POTENT AND SELECTIVE DDR1/2 INHIBITORS
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1;
COMPND 3 CHAIN: A;
COMPND 4 FRAGMENT: RESIDEUS 576-894;
COMPND 5 SYNONYM: EPITHELIAL DISCOIDIN DOMAIN RECEPTOR 1,CD167 ANTIGEN-LIKE
COMPND 6 FAMILY MEMBER A,CELL ADHESION KINASE,DISCOIDIN RECEPTOR TYROSINE
COMPND 7 KINASE,HGK2,MAMMARY CARCINOMA KINASE 10,MCK-10,PROTEIN-TYROSINE
COMPND 8 KINASE 3A,PROTEIN-TYROSINE KINASE RTK-6,TRK E,TYROSINE KINASE DDR,
COMPND 9 TYROSINE-PROTEIN KINASE CAK;
COMPND 10 EC: 2.7.10.1;
COMPND 11 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: DDR1, CAK, EDDR1, NEP, NTRK4, PTK3A, RTK6, TRKE;
SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA;
SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM;
SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108
KEYWDS DDR1, FRAGMENTS, TRANSFERASE
EXPDTA X-RAY DIFFRACTION
AUTHOR C.MURRAY,V.BERDINI,I.BUCK,M.CARR,A.CLEASBY,J.COYLE,J.CURRY,J.DAY,
AUTHOR 2 K.HEARN,A.IQBAL,L.LEE,V.MARTINS,P.MORTENSON,J.MUNCK,L.PAGE,S.PATEL,
AUTHOR 3 S.ROOMANS,T.KIRSTEN,G.SAXTY
REVDAT 2 13-NOV-24 5BVW 1 REMARK
REVDAT 1 05-AUG-15 5BVW 0
JRNL AUTH C.W.MURRAY,V.BERDINI,I.M.BUCK,M.E.CARR,A.CLEASBY,J.E.COYLE,
JRNL AUTH 2 J.E.CURRY,J.E.DAY,P.J.DAY,K.HEARN,A.IQBAL,L.Y.LEE,V.MARTINS,
JRNL AUTH 3 P.N.MORTENSON,J.M.MUNCK,L.W.PAGE,S.PATEL,S.ROOMANS,K.SMITH,
JRNL AUTH 4 E.TAMANINI,G.SAXTY
JRNL TITL FRAGMENT-BASED DISCOVERY OF POTENT AND SELECTIVE DDR1/2
JRNL TITL 2 INHIBITORS.
JRNL REF ACS MED.CHEM.LETT. V. 6 798 2015
JRNL REFN ISSN 1948-5875
JRNL PMID 26191369
JRNL DOI 10.1021/ACSMEDCHEMLETT.5B00143
REMARK 2
REMARK 2 RESOLUTION. 1.94 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : REFMAC 2.11.6
REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK 3 : NICHOLLS,WINN,LONG,VAGIN
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.94
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.80
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 97.4
REMARK 3 NUMBER OF REFLECTIONS : 25195
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.186
REMARK 3 R VALUE (WORKING SET) : 0.184
REMARK 3 FREE R VALUE : 0.234
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.020
REMARK 3 FREE R VALUE TEST SET COUNT : 1266
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 2212
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 41
REMARK 3 SOLVENT ATOMS : 287
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.09
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 4.55940
REMARK 3 B22 (A**2) : -3.15540
REMARK 3 B33 (A**2) : -1.40400
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED OVERALL COORDINATE ERROR.
REMARK 3 ESU BASED ON R VALUE (A): NULL
REMARK 3 ESU BASED ON FREE R VALUE (A): NULL
REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL
REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA
REMARK 3 BOND LENGTH (A) : NULL ; NULL
REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL
REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL
REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL
REMARK 3
REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL
REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL
REMARK 3
REMARK 3 NON-BONDED CONTACT RESTRAINTS.
REMARK 3 SINGLE TORSION (A) : NULL ; NULL
REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL
REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL
REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL
REMARK 3
REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS.
REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL
REMARK 3 PLANAR (DEGREES) : NULL ; NULL
REMARK 3 STAGGERED (DEGREES) : NULL ; NULL
REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 5BVW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 05-JUN-15.
REMARK 100 THE DEPOSITION ID IS D_1000210625.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 22-SEP-08
REMARK 200 TEMPERATURE (KELVIN) : 93
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : ESRF
REMARK 200 BEAMLINE : ID29
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.976
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : PIXEL
REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM
REMARK 200 DATA SCALING SOFTWARE : SCALA, AIMLESS
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25196
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900
REMARK 200 RESOLUTION RANGE LOW (A) : 33.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 97.0
REMARK 200 DATA REDUNDANCY : 2.700
REMARK 200 R MERGE (I) : 0.05600
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 8.6000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.94
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.02
REMARK 200 COMPLETENESS FOR SHELL (%) : 97.4
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : 0.46800
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.600
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 47.28
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.33
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 18.0%W/V PEG 3350, 0.2M NH4I, VAPOR
REMARK 280 DIFFUSION, TEMPERATURE 277K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 30.82100
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 37.89350
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.39000
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 37.89350
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 30.82100
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.39000
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 2080 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 14060 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -4.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLY A 590
REMARK 465 ALA A 591
REMARK 465 MET A 592
REMARK 465 GLY A 593
REMARK 465 SER A 594
REMARK 465 ALA A 595
REMARK 465 VAL A 596
REMARK 465 GLY A 597
REMARK 465 ASP A 598
REMARK 465 GLY A 599
REMARK 465 PRO A 600
REMARK 465 PRO A 601
REMARK 465 ARG A 602
REMARK 465 VAL A 603
REMARK 465 PRO A 632
REMARK 465 GLN A 633
REMARK 465 ASP A 634
REMARK 465 LEU A 635
REMARK 465 VAL A 636
REMARK 465 SER A 637
REMARK 465 LEU A 638
REMARK 465 ASP A 639
REMARK 465 PHE A 640
REMARK 465 PRO A 641
REMARK 465 LEU A 642
REMARK 465 ASN A 643
REMARK 465 VAL A 644
REMARK 465 ARG A 645
REMARK 465 LYS A 646
REMARK 465 GLY A 647
REMARK 465 ALA A 722
REMARK 465 ALA A 723
REMARK 465 GLU A 724
REMARK 465 GLY A 725
REMARK 465 ALA A 726
REMARK 465 PRO A 727
REMARK 465 GLY A 728
REMARK 465 ASP A 729
REMARK 465 GLY A 730
REMARK 465 GLN A 731
REMARK 465 ALA A 732
REMARK 465 ALA A 733
REMARK 465 GLN A 734
REMARK 465 GLY A 735
REMARK 465 MET A 787
REMARK 465 SER A 788
REMARK 465 ARG A 789
REMARK 465 ASN A 790
REMARK 465 THR A 912
REMARK 465 VAL A 913
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 GLN A 693 -104.94 -73.03
REMARK 500 ARG A 765 -12.24 73.51
REMARK 500 ASP A 766 49.85 -142.25
REMARK 500 PHE A 785 118.50 40.34
REMARK 500 GLU A 907 -65.87 -124.77
REMARK 500
REMARK 500 REMARK: NULL
REMARK 525
REMARK 525 SOLVENT
REMARK 525
REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT
REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST
REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT
REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE
REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER;
REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE
REMARK 525 NUMBER; I=INSERTION CODE):
REMARK 525
REMARK 525 M RES CSSEQI
REMARK 525 HOH A1383 DISTANCE = 6.40 ANGSTROMS
REMARK 525 HOH A1384 DISTANCE = 6.46 ANGSTROMS
REMARK 525 HOH A1385 DISTANCE = 6.52 ANGSTROMS
REMARK 525 HOH A1386 DISTANCE = 6.84 ANGSTROMS
REMARK 525 HOH A1387 DISTANCE = 7.14 ANGSTROMS
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue IOD A 1002
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue IOD A 1003
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue IOD A 1004
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue IOD A 1005
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC5
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue IOD A 1006
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC6
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue IOD A 1007
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC7
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue IOD A 1008
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC8
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue 1N1 A 1009
DBREF 5BVW A 595 913 UNP Q08345 DDR1_HUMAN 576 894
SEQADV 5BVW GLY A 590 UNP Q08345 EXPRESSION TAG
SEQADV 5BVW ALA A 591 UNP Q08345 EXPRESSION TAG
SEQADV 5BVW MET A 592 UNP Q08345 EXPRESSION TAG
SEQADV 5BVW GLY A 593 UNP Q08345 EXPRESSION TAG
SEQADV 5BVW SER A 594 UNP Q08345 EXPRESSION TAG
SEQRES 1 A 324 GLY ALA MET GLY SER ALA VAL GLY ASP GLY PRO PRO ARG
SEQRES 2 A 324 VAL ASP PHE PRO ARG SER ARG LEU ARG PHE LYS GLU LYS
SEQRES 3 A 324 LEU GLY GLU GLY GLN PHE GLY GLU VAL HIS LEU CYS GLU
SEQRES 4 A 324 VAL ASP SER PRO GLN ASP LEU VAL SER LEU ASP PHE PRO
SEQRES 5 A 324 LEU ASN VAL ARG LYS GLY HIS PRO LEU LEU VAL ALA VAL
SEQRES 6 A 324 LYS ILE LEU ARG PRO ASP ALA THR LYS ASN ALA ARG ASN
SEQRES 7 A 324 ASP PHE LEU LYS GLU VAL LYS ILE MET SER ARG LEU LYS
SEQRES 8 A 324 ASP PRO ASN ILE ILE ARG LEU LEU GLY VAL CYS VAL GLN
SEQRES 9 A 324 ASP ASP PRO LEU CYS MET ILE THR ASP TYR MET GLU ASN
SEQRES 10 A 324 GLY ASP LEU ASN GLN PHE LEU SER ALA HIS GLN LEU GLU
SEQRES 11 A 324 ASP LYS ALA ALA GLU GLY ALA PRO GLY ASP GLY GLN ALA
SEQRES 12 A 324 ALA GLN GLY PRO THR ILE SER TYR PRO MET LEU LEU HIS
SEQRES 13 A 324 VAL ALA ALA GLN ILE ALA SER GLY MET ARG TYR LEU ALA
SEQRES 14 A 324 THR LEU ASN PHE VAL HIS ARG ASP LEU ALA THR ARG ASN
SEQRES 15 A 324 CYS LEU VAL GLY GLU ASN PHE THR ILE LYS ILE ALA ASP
SEQRES 16 A 324 PHE GLY MET SER ARG ASN LEU TYR ALA GLY ASP TYR TYR
SEQRES 17 A 324 ARG VAL GLN GLY ARG ALA VAL LEU PRO ILE ARG TRP MET
SEQRES 18 A 324 ALA TRP GLU CYS ILE LEU MET GLY LYS PHE THR THR ALA
SEQRES 19 A 324 SER ASP VAL TRP ALA PHE GLY VAL THR LEU TRP GLU VAL
SEQRES 20 A 324 LEU MET LEU CYS ARG ALA GLN PRO PHE GLY GLN LEU THR
SEQRES 21 A 324 ASP GLU GLN VAL ILE GLU ASN ALA GLY GLU PHE PHE ARG
SEQRES 22 A 324 ASP GLN GLY ARG GLN VAL TYR LEU SER ARG PRO PRO ALA
SEQRES 23 A 324 CYS PRO GLN GLY LEU TYR GLU LEU MET LEU ARG CYS TRP
SEQRES 24 A 324 SER ARG GLU SER GLU GLN ARG PRO PRO PHE SER GLN LEU
SEQRES 25 A 324 HIS ARG PHE LEU ALA GLU ASP ALA LEU ASN THR VAL
HET IOD A1001 1
HET IOD A1002 1
HET IOD A1003 1
HET IOD A1004 1
HET IOD A1005 1
HET IOD A1006 1
HET IOD A1007 1
HET IOD A1008 1
HET 1N1 A1009 33
HETNAM IOD IODIDE ION
HETNAM 1N1 N-(2-CHLORO-6-METHYLPHENYL)-2-({6-[4-(2-HYDROXYETHYL)
HETNAM 2 1N1 PIPERAZIN-1-YL]-2-METHYLPYRIMIDIN-4-YL}AMINO)-1,3-
HETNAM 3 1N1 THIAZOLE-5-CARBOXAMIDE
HETSYN 1N1 DASATINIB
FORMUL 2 IOD 8(I 1-)
FORMUL 10 1N1 C22 H26 CL N7 O2 S
FORMUL 11 HOH *287(H2 O)
HELIX 1 AA1 PRO A 606 SER A 608 5 3
HELIX 2 AA2 THR A 662 ARG A 678 1 17
HELIX 3 AA3 ASP A 708 ALA A 715 1 8
HELIX 4 AA4 SER A 739 LEU A 760 1 22
HELIX 5 AA5 ALA A 768 ARG A 770 5 3
HELIX 6 AA6 GLU A 776 PHE A 778 5 3
HELIX 7 AA7 TYR A 792 TYR A 796 5 5
HELIX 8 AA8 PRO A 806 MET A 810 5 5
HELIX 9 AA9 ALA A 811 GLY A 818 1 8
HELIX 10 AB1 THR A 821 MET A 838 1 18
HELIX 11 AB2 THR A 849 ASP A 863 1 15
HELIX 12 AB3 PRO A 877 TRP A 888 1 12
HELIX 13 AB4 GLU A 891 ARG A 895 5 5
HELIX 14 AB5 PRO A 897 GLU A 907 1 11
HELIX 15 AB6 ASP A 908 ASN A 911 5 4
SHEET 1 AA1 5 LEU A 610 GLU A 618 0
SHEET 2 AA1 5 GLU A 623 VAL A 629 -1 O LEU A 626 N GLU A 614
SHEET 3 AA1 5 LEU A 650 ILE A 656 -1 O VAL A 652 N CYS A 627
SHEET 4 AA1 5 CYS A 698 ASP A 702 -1 O MET A 699 N LYS A 655
SHEET 5 AA1 5 LEU A 687 VAL A 690 -1 N LEU A 688 O ILE A 700
SHEET 1 AA2 2 GLN A 717 LEU A 718 0
SHEET 2 AA2 2 THR A 737 ILE A 738 1 O ILE A 738 N GLN A 717
SHEET 1 AA3 2 CYS A 772 VAL A 774 0
SHEET 2 AA3 2 ILE A 780 ILE A 782 -1 O LYS A 781 N LEU A 773
SSBOND 1 CYS A 691 CYS A 698 1555 1555 2.05
CISPEP 1 ASP A 604 PHE A 605 0 -13.87
CISPEP 2 ASP A 695 PRO A 696 0 -8.95
SITE 1 AC1 2 LEU A 883 ARG A 886
SITE 1 AC2 5 GLY A 619 GLN A 620 GLY A 622 LYS A 655
SITE 2 AC2 5 IOD A1008
SITE 1 AC3 3 ASP A 681 PRO A 682 ARG A 686
SITE 1 AC4 1 HIS A 902
SITE 1 AC5 2 PRO A 659 SER A 739
SITE 1 AC6 1 LEU A 718
SITE 1 AC7 2 GLY A 619 IOD A1003
SITE 1 AC8 13 LEU A 616 ALA A 653 LYS A 655 MET A 676
SITE 2 AC8 13 THR A 701 ASP A 702 TYR A 703 MET A 704
SITE 3 AC8 13 GLU A 705 GLY A 707 LEU A 773 ALA A 783
SITE 4 AC8 13 PHE A 785
CRYST1 61.642 72.780 75.787 90.00 90.00 90.00 P 21 21 21 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.016223 0.000000 0.000000 0.00000
SCALE2 0.000000 0.013740 0.000000 0.00000
SCALE3 0.000000 0.000000 0.013195 0.00000